Results 101 to 110 of about 136,379 (287)

Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations [PDF]

, 2020
Hyun Jung Lee, Dong‐Hoon Shin, Joon‐Young Park, So Young Kim, Chungsu Hwang, Jung Hee Lee, Jee Yeon Kim, Mee Young Sol, Jong Kil Nam   +8 more
openalex   +1 more source

Loss of METTL3 m6A methyltransferase results in short‐term progression and poor treatment outcome of bladder cancer patients

International Journal of Cancer, Volume 158, Issue 3, Page 763-774, 1 February 2026.
What's new? Bladder cancer exhibits a highly heterogeneous molecular landscape and treatment response. The dysregulation of RNA modifications such as m6A has been involved in cancer initiation and progression. This study comprehensively analyzed the expression of the main catalytic component of the m6A methylation machinery in bladder tumors across one
Katerina‐Marina Pilala, Stella Koroneou, Maria‐Alexandra Papadimitriou, Konstantina Panoutsopoulou, Konstantinos Soureas, Georgios‐Christos Giagkos, Panagiotis Levis, Dimitrios Linardoutsos, Konstantinos Stravodimos, Margaritis Avgeris, Andreas Scorilas   +10 more
wiley   +1 more source

Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma [PDF]

, 2023
Baodong Wang, Mei Li, Rongshan Li
openalex   +1 more source

Accelerating 2D Kidney Magnetic Resonance Fingerprinting Using Deep Learning Based Tissue Quantification

Journal of Magnetic Resonance Imaging, Volume 63, Issue 2, Page 525-535, February 2026.
ABSTRACT Background Magnetic Resonance Fingerprinting (MRF) is a technique that can provide rapid quantification of multiple tissue properties. Deep learning may potentially contribute to an accelerated acquisition of MRF. Purpose (1) To develop a deep learning method to accelerate the acquisition for kidney MRF; (2) to evaluate its performance in ...
Zhiqing Yin, Huay Din, Jessie E. P. Sun, Christina J. MacAskill, Sree Harsha Tirumani, Pew‐Thian Yap, Mark Griswold, Chris A. Flask, Yong Chen   +8 more
wiley   +1 more source

Radiogenomics: Current Understandings and Future Perspectives

MedComm, Volume 7, Issue 2, February 2026.
Radiogenomics links imaging phenotypes with genetic variations, offering potential for comprehensive understanding, cost‐effective diagnosis, and prognosis prediction to advance personalized medicine. However, its clinical application remains limited by several challenges.
Xinyu Zhang, Qingpei Lai, Jin Cao, Jerry Chi Fung Ching, Xinzhi Teng, Jiang Zhang, Shara Wee Yee Lee, Ge Ren, Jing Cai   +8 more
wiley   +1 more source

Metastatic papillary renal cell carcinoma in the era of targeted therapy – a retrospective study from three European academic centres [PDF]

, 2018
Maria Stenman, Michael Staehler, Bernadett Szabados, Per Sandström, Anna Laurell, Magnus Lindskog, Ulrika Harmenberg   +6 more
openalex   +1 more source

Noninvasive Early Detection and Recurrence Monitoring for Non‐Muscle‐Invasive Bladder Cancer via Urine Tumor DNA: A Prospective Clinical Study

MedComm, Volume 7, Issue 2, February 2026.
In NMIBC surveillance, positive postoperative utLIFE‐UC results before initial follow‐up cystoscopy were significantly associated with increased relapse risk. Longitudinal analysis showed that positive utLIFE‐UC results at any time after TURBT correlated with worse recurrence‐free survival, while sustained negative results predicted recurrence‐free ...
Junlong Wu, Shengming Jin, Qianming Bai, Huina Wang, Huanqing Cheng, Xiaoyan Zhou, Yijun Shen, Chunguang Ma, Chengyuan Gu, Hui Chen, Yafeng Zhang, Libin Chen, Shahrokh F. Shariat, Feng Lou, Shanbo Cao, Yiping Zhu, Dingwei Ye   +16 more
wiley   +1 more source

Tumor‐Associated Macrophages as Therapeutic Targets: Deciphering Interaction Networks and Advancing Clinical Translation

MedComm, Volume 7, Issue 2, February 2026.
Tumor‐associated macrophages are the most abundant immune cells in the tumor microenvironment, driving malignant progression and treatment resistance. This review summarizes the protumor mechanisms of TAMs (including phagocytosis modulation, metabolic reprogramming, exosomal communication, and immune interactions), evaluates three major strategies ...
Wurihan Bao, Xiaojie Qu, Yiqi Wang, Dan Huang, Huiling Zhang, Mingyuan Dong, Han Sun, Zhaogang Yang, Xuefeng Li   +8 more
wiley   +1 more source

Papillary renal cell carcinoma with high‐ABCC2 shows an immune‐evasive profile associated with favorable response to immunotherapy

The Journal of Pathology, Volume 268, Issue 2, Page 188-199, February 2026.
Abstract The use of immune checkpoint inhibitors is a promising therapeutic strategy for metastatic papillary renal cell carcinoma (PRCC); however, predictive biomarkers remain limited. PRCCs with high ABCC2 expression represent an aggressive subset frequently associated with metastasis.
Vincent Francis Castillo, Abraam Zakhary, Fabio Rotondo, Caterina Di Ciano‐Oliveira, Malek Hamdani, Emelyn Adona, Theodorus van der Kwast, Kiril Trpkov, Rola Saleeb   +8 more
wiley   +1 more source

Chromophobe Renal Cell Carcinoma.

Online Journal of Health & Allied Sciences, 2013
Renal cell carcinoma is the most common neoplasm of the kidney comprised of different histological variants. Chromophobe renal cell carcinoma (ChRCC) is a rare subtype of renal cell carcinoma (RCC) mainly diagnosed in the sixth decade of life.
Jyotsna Vijaykumar Wader, Sujata S Kumbhar, Huddedar AD, Wasim GM Khatib   +3 more
doaj